Takuma Kagami

Influence of daily versus alternate-day dosing of vonoprazan on intragastric pH, serum gastrin, and the antiplatelet function of clopidogrel

Tomohiro Higuchi, Mihoko Yamade, Satoru Takahashi, Satoshi Tamura et autres

jp (code pays fourni par la source)

Effects of pirenzepine on vonoprazan-induced gastric acid inhibition and hypergastrinemia

Takahiro Suzuki, Tomohiro Higuchi, Takuma Kagami, Takahiro Uotani et autres

jp (code pays fourni par la source)

The first evidence for SLFN11 expression as an independent prognostic factor for patients with esophageal cancer after chemoradiotherapy

Takuma Kagami, Mihoko Yamade, Takahiro Suzuki, Takahiro Uotani et autres

BACKGROUND: Schlafen 11 (SLFN11) was recently identified as a dominant determinant of sensitivity to DNA-targeting agents including platinum-based drugs. SLFN11 also reportedly enhances cellular radiosensitivity. In this study, we examined the prognostic value of SLFN11 expression in esophageal squamous cell carcinoma (ESCC) …

jp, us (code pays fourni par la source)

The first evidence for SLFN11 expression as an independent prognostic factor for patients with esophageal cancer after chemoradiotherapy

Takuma Kagami, Mihoko Yamade, Takahiro Suzuki, Takahiro Uotani et autres

jp (code pays fourni par la source)

Estimation of the degree of gastric mucosal atrophy based on serum pepsinogen levels after eradication of Helicobacter pylori

Takahiro Suzuki, Tomohiro Higuchi, Takuma Kagami, Mihoko Yamade et autres

Abstract Background Serum pepsinogen (PG) levels correlate with the degree of gastric mucosal inflammation and atrophy, which correlate with gastric cancer risk, in patients infected with Helicobacter pylori (H. pylori). Serum PG levels change after eradication of H. pylori, but it is …

jp (code pays fourni par la source)

The effect of early trough level of infliximab on subsequent disease course in patients with Crohn disease

Natsuki Ishida, Takahiro Miyazu, Tomohiro Sugiyama, Satoshi Tamura et autres

Decreased trough level of infliximab (TLI) is associated with diminished efficacy in patients with Crohn disease (CD). We examined whether TLI at 14 weeks subsequent to the start of infliximab (IFX) treatment would impact long-term clinical course.Serum IFX levels and antibodies to …

jp (code pays fourni par la source)

The First Evidence for SLFN11 Expression As An Independent Prognostic Factor for Patients with Esophageal Cancer After Chemoradiotherapy

Takuma Kagami, Mihoko Yamade, Takahiro Suzuki, Takahiro Uotani et autres

Abstract Background:Schlafen 11 (SLFN11) was recently identified as a dominant determinant of sensitivity to DNA-targeting agents including platinum-based drugs. SLFN11 also reportedly enhances cellular radiosensitivity. In this study, we examined the prognostic value of SLFN11 expression in esophageal squamous cell carcinoma (ESCC) …

jp (code pays fourni par la source)

Effect of ulcerative colitis duration on the usefulness of immunochemical fecal occult blood test result as a disease activity biomarker

Natsuki Ishida, Takahiro Miyazu, Tomoharu Matsuura, Ryosuke Takano et autres

jp (code pays fourni par la source)

Sa1343 CLASSIFICATION OF AUTOIMMUNE GASTRITIS BASED ON THE STATUS OF POLYGLANDULAR POLYGLANDULAR AUTOIMMUNE SYNDROME

Takahisa Furuta, Takuma Kagami, Mihoko Yamade, Takahiro Suzuki et autres

Tu1372 INFULUENCE OF DAILY OR ALTERNATE-DAY DOSING OF VONOPRAZAN ON INTRAGASTRIC PH AND SERUM GASTRIN, AND THE ANTIPLATELET EFFECT OF CLOPIDOGREL.

Tomohiro Higuchi, Takahiro Suzuki, Takuma Kagami, Shinya Tani et autres

Mo1070 THE FIRSR EVIDENCE FOR SLFN11 EXPRESSION AS AN INDEPENDENT PROGNOSTIC FACTOR FOR PATIENTS WITH ESOPHAGEAL CANCER AFTER CHEMORADIOTHERAPY

Takuma Kagami, Mihoko Yamade, Takahiro Suzuki, Takahiro Uotani et autres

Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis

Natsuki Ishida, Takahiro Miyazu, Ryosuke Takano, Satoshi Tamura et autres

BACKGROUND: Prostaglandin E-major urinary metabolite (PGE-MUM) may be a novel biomarker for evaluating disease activity in ulcerative colitis (UC). We compared its usefulness to that of the fecal immunochemical occult blood test (FIT). METHODS: PGE-MUM and FIT measurements were performed of 92 …

jp (code pays fourni par la source)